X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
transplantation (36) 36
kidney transplantation (33) 33
index medicus (28) 28
female (24) 24
male (24) 24
middle aged (21) 21
surgery (21) 21
adult (20) 20
urology & nephrology (18) 18
immunology (13) 13
immunosuppressive agents - therapeutic use (11) 11
kidney transplantation - adverse effects (11) 11
kidneys (11) 11
treatment outcome (11) 11
immunosuppression (10) 10
renal transplantation (10) 10
graft rejection - immunology (9) 9
kidney-transplantation (9) 9
retrospective studies (9) 9
antibody-mediated rejection (8) 8
recipients (8) 8
survival (8) 8
aged (7) 7
anti-hla antibodies (7) 7
graft rejection - prevention & control (7) 7
time factors (7) 7
acute rejection (6) 6
follow-up studies (6) 6
graft survival (6) 6
immunosuppression - methods (6) 6
acute humoral rejection (5) 5
donor-specific antibodies (5) 5
hla antigens - immunology (5) 5
rejection (5) 5
risk assessment (5) 5
rituximab (5) 5
survival rate (5) 5
tacrolimus (5) 5
young adult (5) 5
analysis (4) 4
animals (4) 4
biopsy (4) 4
costimulation blockade (4) 4
disease (4) 4
expanded criteria donors (4) 4
hla antibodies (4) 4
immunization (4) 4
immunosuppressive agents - pharmacology (4) 4
kidney - pathology (4) 4
life sciences (4) 4
nephropathy (4) 4
organ transplant recipients (4) 4
prognosis (4) 4
renal-allograft rejection (4) 4
risk factors (4) 4
risk-factors (4) 4
therapy (4) 4
transplantation rénale (4) 4
transplants & implants (4) 4
acute disease (3) 3
adolescent (3) 3
age factors (3) 3
allografts (3) 3
anti-cd20 antibodies (3) 3
antibodies (3) 3
b-lymphocytes - immunology (3) 3
belatacept (3) 3
calcineurine inhibitors (3) 3
care and treatment (3) 3
child (3) 3
complement c4d (3) 3
diabetes (3) 3
drug administration schedule (3) 3
drug therapy, combination (3) 3
epitopes (3) 3
equity (3) 3
glomerular filtration rate (3) 3
graft rejection (3) 3
graft rejection - pathology (3) 3
immunosuppression - adverse effects (3) 3
immunosuppressive agents - administration & dosage (3) 3
immunosuppressive agents - adverse effects (3) 3
isoantibodies - immunology (3) 3
kidney failure, chronic - surgery (3) 3
kidney transplantation - methods (3) 3
kidney transplantation - mortality (3) 3
mtor inhibitors (3) 3
organ donation (3) 3
organ shortage (3) 3
organ transplant trafficking and tourism (3) 3
patient outcomes (3) 3
renal biopsy (3) 3
renal-transplantation (3) 3
t-lymphocytes - immunology (3) 3
transplantation, homologous (3) 3
[ sdv.imm ] life sciences [q-bio]/immunology (2) 2
acute kidney injury - etiology (2) 2
adults (2) 2
age (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, ISSN 1600-6135, 05/2018, Volume 18, Issue 5, pp. 1292 - 1292
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 4, pp. 303 - 312
This study shows that the mTORC pathway is central to the antiphospholipid syndrome. Among patients with kidney transplants and antiphospholipid syndrome, 70%... 
RAPAMYCIN | BETA-GLYCOPROTEIN-I | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ANGIOPLASTY | ANTIBODY-MEDIATED REJECTION | POLYCYSTIC KIDNEY-DISEASE | SMOOTH-MUSCLE-CELLS | ANTI-BETA-GLYCOPROTEIN-I ANTIBODIES | SYNDROME NEPHROPATHY | VASCULOPATHY | Endothelium, Vascular - cytology | Cell Proliferation | Kidney - blood supply | Kidney - pathology | TOR Serine-Threonine Kinases - metabolism | Humans | Immunoglobulin G | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Antiphospholipid Syndrome - complications | TOR Serine-Threonine Kinases - antagonists & inhibitors | Autopsy | Adult | Female | Antiphospholipid Syndrome - metabolism | Immunosuppressive Agents - pharmacology | Kidney Diseases - metabolism | Sirolimus - therapeutic use | Antiphospholipid Syndrome - drug therapy | Kidney Transplantation | Sirolimus - pharmacology | Antibodies, Antiphospholipid - metabolism | Analysis of Variance | Endothelium, Vascular - metabolism | Endothelium, Vascular - pathology | Kidney Diseases - etiology | Metabolic Networks and Pathways - drug effects | Care and treatment | Rapamycin | Health aspects | Antiphospholipid syndrome | TOR protein | Cell proliferation | Lupus | Heart attacks | Kidneys | Transplants & implants | Sirolimus | AKT protein | Antiphospholipid antibodies | Kinases | Thrombosis | Endothelial cells | Endothelium | 1-Phosphatidylinositol 3-kinase | Vascular diseases | Nephropathy | Biopsy | Autoimmune diseases | Kidney transplantation
Journal Article
Nephrologie & Therapeutique, ISSN 1769-7255, 04/2016, Volume 12, p. S125-S130
En transplantation d'organe, le degre d'incompatibilite des molecules human leucocyte antigen (HLA) entre un receveur et son donneur est apprecie... 
Transplantation of organs, tissues, etc
Journal Article
Néphrologie & Thérapeutique, ISSN 1769-7255, 04/2016, Volume 12, pp. S125 - S130
En transplantation d’organe, le degré d’incompatibilité des molécules (HLA) entre un receveur et son donneur est apprécié traditionnellement par la comparaison... 
Anti-HLA antibodies | Rejet humoral | Anticorps anti-HLA | Épitopes | Epitopes | Transplantation rénale | Antibody-mediated rejection | Kidney transplantation
Journal Article
Nephrologie et Therapeutique, ISSN 1769-7255, 04/2016, Volume 12, pp. S125 - S130
In organ transplantation, HLA compatibility between a donor and a recipient is currently assessed through the comparison of their HLA antigens and the sole... 
Anti-HLA antibodies | Epitopes | Antibody-mediated rejection | Kidney transplantation
Journal Article
Journal Article
Nephrologie & therapeutique, 04/2016, Volume 12 Suppl 1, p. S125
In organ transplantation, HLA compatibility between a donor and a recipient is currently assessed through the comparison of their HLA antigens and the sole... 
Immunologic Factors | Humans | HLA Antigens - immunology | Isoantibodies - immunology | Kidney Transplantation | Tissue Donors | Histocompatibility Testing - methods
Journal Article
Drugs, ISSN 0012-6667, 11/2010, Volume 70, Issue 16, pp. 2121 - 2131
New immunosuppressive drugs have greatly decreased the frequency of graft failure due to acute rejection but have had little impact on long-term graft... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Research-and-development | Corticosteroids | Sirolimus | Belatacept | Efalizumab | Renal-transplant-rejection | Muromonab-CD3 | Renal-transplant | Mycophenolate-sodium | Alefacept | Tacrolimus | Ciclosporin | Antithymocyte-globulin | Mycophenolate-mofetil | Everolimus | Odulimomab | COSTIMULATION BLOCKADE | NONHUMAN-PRIMATES | RHEUMATOID-ARTHRITIS | RENAL-ALLOGRAFT REJECTION | ANTI-CD40 MONOCLONAL-ANTIBODY | MULTICENTER TRIAL | IN-VIVO | REGULATORY T-CELLS | CD40 LIGAND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | IMMUNOSUPPRESSIVE DRUGS | CD40 Antigens - antagonists & inhibitors | Immunosuppression - methods | Graft Rejection - prevention & control | Humans | Immunosuppressive Agents - therapeutic use | B7-1 Antigen - metabolism | Molecular Targeted Therapy | CD28 Antigens - metabolism | Animals | Immunosuppression - adverse effects | T-Lymphocytes - metabolism | Lymphocyte Activation - drug effects | T-Lymphocytes - drug effects | Immunosuppressive Agents - adverse effects | CD40 Ligand - antagonists & inhibitors | Graft Survival - drug effects | Immunosuppressive Agents - pharmacology | Kidney Transplantation - adverse effects | Antigens | Immunoglobulins | Kidneys | Targeting (Nuclear strategy) | Organ transplant recipients | Transplantation | T cells | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 07/2018, Volume 102 Suppl 7S-1, pp. S629 - S629
INTRODUCTIONSolid-phase bead-based assays have become the cornerstone for anti-HLA sensitization assessment in patients waiting for an organ transplant.... 
Journal Article
Transplantation, ISSN 0041-1337, 10/2019, Volume 103, Issue 10, pp. 2150 - 2156
BACKGROUND.Belatacept could be the treatment of choice in renal-transplant recipients with renal dysfunction attributed to calcineurin inhibitor (CNI)... 
Kidneys | Patient outcomes | Organ transplant recipients | Physiological aspects | Belatacept | Transplantation | Drug therapy | Testing
Journal Article
Transplantation, ISSN 0041-1337, 07/2018, Volume 102 Suppl 7S-1, pp. S212 - S213
INTRODUCTIONGeneralization of solid-phase bead-based assays has dramatically modified the definition of HLA sensitization in patients waiting for an organ... 
Journal Article